Literature DB >> 28927137

Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report.

Masahide Yamamoto1, Sayaka Suzuki1, Jun-Ichi Mukae1, Keisuke Tanaka1, Ken Watanabe1, Gaku Oshikawa1, Tetsuya Fukuda1, Naomi Murakami1, Osamu Miura1.   

Abstract

Atypical chronic myeloid leukemia (aCML) is a rare subtype of myelodysplastic/myeloproliferative neoplasm (MDS/MPN). Although recurrent chromosomal and genetic abnormalities are frequently observed in aCML, none are specific to this type of leukemia. The present study reported a case of aCML associated with i(X)(p10), a rare recurrent chromosomal abnormality of hematological malignancy. A 40-year-old female was referred to the Tokyo Medical and Dental University Hospital (Tokyo, Japan) due to slight leukocytosis and anemia. A bone marrow aspiration revealed 4% blasts and granulocytic hyperplasia with dysplasia. A G-banded cytogenetic analysis of the bone marrow cells revealed 46, X, isochromosome X(iX)(p10) in all metaphases. The percentage of the neutrophil precursors promyelocytes, myelocytes and metamyelocytes in the peripheral blood was >10% throughout the clinical course of the patient, which resulted in a diagnosis of atypical chronic myeloid leukemia. Treatment with hydroxycarbamide was not able to effectively alleviate leukocytosis, and the disease progressed with the appearance of an additional cytogenetic abnormality, t(10;17)(p13;q21). Subsequently, the patient underwent allogeneic stem cell transplantation from a sibling donor, and subsequent cytogenetic analysis revealed a normal karyotype with full donor chimerism. The isodicentric X(idicX)(q13) mutation is a similar abnormality to i(X)(p10) and may result in a loss of the X-inactive specific transcript gene located at Xq13.2, the deletion of which has been previously reported to result in the development of MDS/MPN in mice. In addition, i(X)(p10) was identified as the sole chromosomal abnormality at the diagnosis of aCML in the case of the present study, which is similar to patients from previous studies of other hematological malignancies and supports the hypothesis that i(X)(p10) may have served a primary role in the leukemogenesis of aCML.

Entities:  

Keywords:  X-inactive specific transcript; atypical chronic myeloid leukemia; i(X)(p10),t(10;17)(p13;q21); idic(X)(q13)

Year:  2017        PMID: 28927137      PMCID: PMC5588062          DOI: 10.3892/ol.2017.6595

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

Review 1.  A case of Down syndrome with acute lymphoblastic leukemia and isochromosome Xp.

Authors:  Jillian M Baker; Max J Coppes; Birgitte Roland
Journal:  Cancer Genet Cytogenet       Date:  2003-11

2.  Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding.

Authors:  M Martineau; R Clark; D M Farrell; J M Hawkins; A V Moorman; L M Secker-Walker
Journal:  Genes Chromosomes Cancer       Date:  1996-09       Impact factor: 5.006

3.  Chromosome rearrangements at telomeric level in hematologic disorders.

Authors:  P Temperani; F Giacobbi; G Gandini; U Torelli; G Emilia
Journal:  Cancer Genet Cytogenet       Date:  1995-09

4.  Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival.

Authors:  L Selleri; G Emilia; P Temperani; E Grassilli; P Zucchini; E Tagliafico; A Bonati; L Venezia; S Ferrari; U Torelli
Journal:  Leukemia       Date:  1989-07       Impact factor: 11.528

Review 5.  Expression and function of a large non-coding RNA gene XIST in human cancer.

Authors:  Sarah M Weakley; Hao Wang; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

6.  Isochromosome (X)(p10) in hematologic disorders: FISH study of 14 new cases show three types of centromere signal patterns.

Authors:  Adewale Adeyinka; Stephanie Smoley; Stephanie Fink; Jessica Sanchez; Daniel L Van Dyke; Gordon Dewald
Journal:  Cancer Genet Cytogenet       Date:  2007-11

7.  Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.

Authors:  Aikaterini Barbouti; Bertil Johansson; Mattias Höglund; Nils Mauritzson; Bodil Strömbeck; Per-Gunnar Nilsson; Hans J Tanke; Anne Hagemeijer; Felix Mitelman; Thoas Fioretos
Journal:  Genes Chromosomes Cancer       Date:  2002-10       Impact factor: 5.006

Review 8.  The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.

Authors:  Jason Gotlib; Julia E Maxson; Tracy I George; Jeffrey W Tyner
Journal:  Blood       Date:  2013-07-29       Impact factor: 22.113

9.  Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia.

Authors:  A Hagemeijer; K Hählen; J Abels
Journal:  Cancer Genet Cytogenet       Date:  1981-03

10.  Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.

Authors:  Sa A Wang; Robert P Hasserjian; Patricia S Fox; Heesun J Rogers; Julia T Geyer; Devon Chabot-Richards; Elizabeth Weinzierl; Joseph Hatem; Jesse Jaso; Rashmi Kanagal-Shamanna; Francesco C Stingo; Keyur P Patel; Meenakshi Mehrotra; Carlos Bueso-Ramos; Ken H Young; Courtney D Dinardo; Srdan Verstovsek; Ramon V Tiu; Adam Bagg; Eric D Hsi; Daniel A Arber; Kathryn Foucar; Raja Luthra; Attilio Orazi
Journal:  Blood       Date:  2014-03-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.